Elehear Beyond vs Otofonix Groove

The Elehear Beyond is a budget-priced OTC hearing aid that delivers A-grade performance in our lab testing, ranking #8 among 65 OTC hearing aids tested. At $431, this 2024 behind-the-ear device earned our Expert's Choice Award and represents strong value in the entry-level price tier. In our testing, the Beyond demonstrated particular strength in speech clarity in quiet environments, scoring 4.3/5—a strong result that sits 1.48 points above the OTC category average. Music streaming quality also impressed at 3.8/5, exceeding the category average by 1.88 points. Speech understanding in noisy settings scored 2.3/5, which is above the category average of 1.48/5 but remains mixed in absolute terms—a common challenge across OTC devices. Feedback handling proved excellent at 4.5/5, essentially matching the category average. Own-voice comfort scored 2.6/5, slightly above the OTC average but mixed overall—users sensitive to their own voice may notice some occlusion effects. The device uses a rechargeable battery and supports streaming to both iPhone and Android devices with hands-free functionality. The Elehear Beyond is well-suited for budget-conscious consumers seeking reliable speech clarity in quieter listening situations and quality audio streaming. Those who frequently encounter challenging noise environments may find the speech-in-noise performance adequate but not exceptional. Within its price range, the Beyond outperforms competitors including the Apple AirPods Pro 2 and Zepp Clarity Omni on overall sound quality.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.